hTERT expression as a potential diagnostic marker.

Cervical cancer is the second type of women cancers, most cases being reported in the developing countries where it represents the main cause for mortality in women. The aim of this study was to clarify the role of hTERT expression levels in cervical carcinogenesis, in each type of cytological diagnostic group (normal/inflammatory, ASCUS, LSIL, HSIL, cancer groups) like potential diagnostic marker. Methods: The smears obtained from 50 women with/without suggestive HPV infection pathology were cytological investigated. The viral testing was based on the presence of HPV DNA using the IINNOLIPA kit and semi-quantitative expression levels of hTERT were estimated in RT-PCR. Results: HPV was present in 84% of the examined cases, but only in 40.48% of them hTERT expression was observed. hTERT mRNA was detected in 17.65% cytologically normal/inflammatory patients, in 30% patients with ASCUS, 61.50% patients presenting LSIL and 70% patients with HSIL/cancer. hTERT mRNA expression was significantly increased in LSIL (p = 0.035) and HSIL/cancer (p=0.0044) as compared with normal group, but hTERT expression in ASCUS patients group does not present statistical significance as compared with the normal group (p=0.37). The association between the expressions of hTERT, the presence of hrHPV as well as dysplasia grade suggests that the hTERT activation may be a central mechanism by which HPV infections lead to malignant transformation. Analysis of hTERT expression can be used in diagnosis to decrease the false-negative cytology tests but only as an adjuvant, requiring correlation with the results of morphological feature. Keyword: diagnostic marker, papillomavirus, hTERT

[1]  J. Ko,et al.  Implication of human telomerase reverse transcriptase in cervical carcinogenesis and cancer recurrence. , 2006, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

[2]  C. Liu,et al.  Telomere attrition predominantly occurs in precursor lesions during in vivo carcinogenic process of the uterine cervix , 2004, Oncogene.

[3]  H. T. Kang,et al.  The role of HPV oncoproteins and cellular factors in maintenance of hTERT expression in cervical carcinoma cells. , 2004, Gynecologic oncology.

[4]  F. Bosman,et al.  Immunohistochemical localization of hTERT protein in human tissues , 2004, Histochemistry and Cell Biology.

[5]  Wei Zhang,et al.  Telomerase activity in cervical intraepithelial neoplasia. , 2001, Chinese medical journal.

[6]  T. Veldman,et al.  Human papillomavirus E6 and Myc proteins associate in vivo and bind to and cooperatively activate the telomerase reverse transcriptase promoter , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[7]  A. Zetterberg,et al.  Amplification of the telomerase reverse transcriptase (hTERT) gene in cervical carcinomas , 2002, Genes, chromosomes & cancer.

[8]  K. Shroyer,et al.  Analysis of telomerase as a diagnostic biomarker of cervical dysplasia and carcinoma , 2002, Oncogene.

[9]  D. Galloway,et al.  E Box-Dependent Activation of Telomerase by Human Papillomavirus Type 16 E6 Does Not Require Induction of c-myc , 2001, Journal of Virology.

[10]  K. Shroyer,et al.  Localization of telomerase hTERT protein and hTR in benign mucosa, dysplasia, and squamous cell carcinoma of the cervix. , 2000, American journal of clinical pathology.

[11]  J. Nowak Telomerase, cervical cancer, and human papillomavirus. , 2000, Clinics in laboratory medicine.

[12]  J. McDougall,et al.  Telomerase activation by the E6 gene product of human papillomavirus type 16 , 1996, Nature.

[13]  C B Harley,et al.  Specific association of human telomerase activity with immortal cells and cancer. , 1994, Science.

[14]  Carol W. Greider,et al.  Identification of a specific telomere terminal transferase activity in tetrahymena extracts , 1985, Cell.

[15]  L. Hayflick THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS. , 1965, Experimental cell research.